MiRXES Leverages INTEGRA’s Automated Pipetting Solutions

Designed to increase the speed and precision of its RT-qPCR workflows.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MiRXES, a biotechnology company based in Singapore, is relying on a range of INTEGRA pipetting systems to increase the speed and precision of its RT-qPCR workflows. Adam Chiow, Senior Research Officer at MiRXES, explained, “We are using a proprietary RT-qPCR technology platform – ID3EAL™ – to identify new microRNA biomarkers and develop diagnostic kits for the early identification of cancer and infectious diseases. We therefore routinely perform RT-qPCR on microRNAs extracted from patient sample...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters